Acute Isovolemic Hemodilution during Major Hepatic Resection - An Initial Report: Does It Safely Reduce the Blood Transfusion Requirement?

Herbert Chen, James V. Sitzmann, Catherine Marcucci, Michael A. Choti

Research output: Contribution to journalArticle

Abstract

Surgical resection remains the mainstay of treatment for patients with hepatic tumors, despite the asso-ciated morbidity including the need for blood transfusion. Acute isovolemic hemodilution (AIH) has been shown to decrease the transfusion requirement for cardiac, urologic, and orthopedic procedures. However, the reported experience with AIH during hepatic resections is limited. Seven patients underwent major hepatic resection from July 1992 to June 1994 with standard AIH. Their clinical parameters were compared with those of nine matched control patients during the same time period. AIH and control patients had similar preoperative laboratory values (hematocrit, bilirubin, and coagulation studies), extent of liver resection, and pathologic diagnoses. Mean tumor diameters were larger in the AIH group (9.3 cm vs. 5.8 cm). Most important, patients managed with AIH required homologous blood transfusions significantly less often than the control group (14% vs. 67%; P = 0.05). Furthermore, if they did receive transfusions, AIH patients needed fewer units of red cells (0.1 ± 0.1 units vs. 1.7 ± 0.6 units). There was no morbidity associated with AIH. AIH can be safely performed in patients undergoing major hepatic resection for malignancy. AIH appears to reduce the number of patients requiring homologous blood transfusion as well as the number of units transfused per patient. This technique warrants further study in a larger prospective, randomized trial.

Original languageEnglish (US)
Pages (from-to)461-466
Number of pages6
JournalJournal of Gastrointestinal Surgery
Volume1
Issue number5
StatePublished - Sep 1997

Fingerprint

Hemodilution
Blood Transfusion
Liver
Orthopedic Procedures
Morbidity
Neoplasms
Hematocrit
Bilirubin
Control Groups

ASJC Scopus subject areas

  • Surgery

Cite this

Acute Isovolemic Hemodilution during Major Hepatic Resection - An Initial Report : Does It Safely Reduce the Blood Transfusion Requirement? / Chen, Herbert; Sitzmann, James V.; Marcucci, Catherine; Choti, Michael A.

In: Journal of Gastrointestinal Surgery, Vol. 1, No. 5, 09.1997, p. 461-466.

Research output: Contribution to journalArticle

Chen, Herbert ; Sitzmann, James V. ; Marcucci, Catherine ; Choti, Michael A. / Acute Isovolemic Hemodilution during Major Hepatic Resection - An Initial Report : Does It Safely Reduce the Blood Transfusion Requirement?. In: Journal of Gastrointestinal Surgery. 1997 ; Vol. 1, No. 5. pp. 461-466.
@article{ca632e243431442a9cdbc215e5a654aa,
title = "Acute Isovolemic Hemodilution during Major Hepatic Resection - An Initial Report: Does It Safely Reduce the Blood Transfusion Requirement?",
abstract = "Surgical resection remains the mainstay of treatment for patients with hepatic tumors, despite the asso-ciated morbidity including the need for blood transfusion. Acute isovolemic hemodilution (AIH) has been shown to decrease the transfusion requirement for cardiac, urologic, and orthopedic procedures. However, the reported experience with AIH during hepatic resections is limited. Seven patients underwent major hepatic resection from July 1992 to June 1994 with standard AIH. Their clinical parameters were compared with those of nine matched control patients during the same time period. AIH and control patients had similar preoperative laboratory values (hematocrit, bilirubin, and coagulation studies), extent of liver resection, and pathologic diagnoses. Mean tumor diameters were larger in the AIH group (9.3 cm vs. 5.8 cm). Most important, patients managed with AIH required homologous blood transfusions significantly less often than the control group (14{\%} vs. 67{\%}; P = 0.05). Furthermore, if they did receive transfusions, AIH patients needed fewer units of red cells (0.1 ± 0.1 units vs. 1.7 ± 0.6 units). There was no morbidity associated with AIH. AIH can be safely performed in patients undergoing major hepatic resection for malignancy. AIH appears to reduce the number of patients requiring homologous blood transfusion as well as the number of units transfused per patient. This technique warrants further study in a larger prospective, randomized trial.",
author = "Herbert Chen and Sitzmann, {James V.} and Catherine Marcucci and Choti, {Michael A.}",
year = "1997",
month = "9",
language = "English (US)",
volume = "1",
pages = "461--466",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Acute Isovolemic Hemodilution during Major Hepatic Resection - An Initial Report

T2 - Does It Safely Reduce the Blood Transfusion Requirement?

AU - Chen, Herbert

AU - Sitzmann, James V.

AU - Marcucci, Catherine

AU - Choti, Michael A.

PY - 1997/9

Y1 - 1997/9

N2 - Surgical resection remains the mainstay of treatment for patients with hepatic tumors, despite the asso-ciated morbidity including the need for blood transfusion. Acute isovolemic hemodilution (AIH) has been shown to decrease the transfusion requirement for cardiac, urologic, and orthopedic procedures. However, the reported experience with AIH during hepatic resections is limited. Seven patients underwent major hepatic resection from July 1992 to June 1994 with standard AIH. Their clinical parameters were compared with those of nine matched control patients during the same time period. AIH and control patients had similar preoperative laboratory values (hematocrit, bilirubin, and coagulation studies), extent of liver resection, and pathologic diagnoses. Mean tumor diameters were larger in the AIH group (9.3 cm vs. 5.8 cm). Most important, patients managed with AIH required homologous blood transfusions significantly less often than the control group (14% vs. 67%; P = 0.05). Furthermore, if they did receive transfusions, AIH patients needed fewer units of red cells (0.1 ± 0.1 units vs. 1.7 ± 0.6 units). There was no morbidity associated with AIH. AIH can be safely performed in patients undergoing major hepatic resection for malignancy. AIH appears to reduce the number of patients requiring homologous blood transfusion as well as the number of units transfused per patient. This technique warrants further study in a larger prospective, randomized trial.

AB - Surgical resection remains the mainstay of treatment for patients with hepatic tumors, despite the asso-ciated morbidity including the need for blood transfusion. Acute isovolemic hemodilution (AIH) has been shown to decrease the transfusion requirement for cardiac, urologic, and orthopedic procedures. However, the reported experience with AIH during hepatic resections is limited. Seven patients underwent major hepatic resection from July 1992 to June 1994 with standard AIH. Their clinical parameters were compared with those of nine matched control patients during the same time period. AIH and control patients had similar preoperative laboratory values (hematocrit, bilirubin, and coagulation studies), extent of liver resection, and pathologic diagnoses. Mean tumor diameters were larger in the AIH group (9.3 cm vs. 5.8 cm). Most important, patients managed with AIH required homologous blood transfusions significantly less often than the control group (14% vs. 67%; P = 0.05). Furthermore, if they did receive transfusions, AIH patients needed fewer units of red cells (0.1 ± 0.1 units vs. 1.7 ± 0.6 units). There was no morbidity associated with AIH. AIH can be safely performed in patients undergoing major hepatic resection for malignancy. AIH appears to reduce the number of patients requiring homologous blood transfusion as well as the number of units transfused per patient. This technique warrants further study in a larger prospective, randomized trial.

UR - http://www.scopus.com/inward/record.url?scp=0013624206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0013624206&partnerID=8YFLogxK

M3 - Article

C2 - 9834379

AN - SCOPUS:0013624206

VL - 1

SP - 461

EP - 466

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 5

ER -